Diseases & Disorders
(G110)
IRS Verified
DX Registered
990 on File
FAMILIES OF SMA
Financial strength (30%)
83/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Families of Spinal Muscular Atrophy is dedicated to creating a treatment and cure by: - Funding and advancing a comprehensive research program; - Supporting SMA families through networking, information and services; - Improving care for all SMA patients; - Educating health professionals and the public about SMA; - Enlisting government support for SMA; - Embracing all touched by SMA in a caring community. Our vision is a world where Spinal Muscular Atrophy is treatable and curable.
Financial Overview — FY 2025
$15.2M
Total Revenue
$14.0M
Total Expenses
$7.4M
Net Assets
53
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.3%
Fundraising Efficiency
264.9%
Operating Reserve
6.35x
Liability-to-Asset
30.3%
Revenue Diversification
50.4%
Executive Compensation
$1.2M
Compared with Peers
FY 2025
Compared with 77 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.3% | 85.3% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.3% | 11.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
13.4% | 0.8% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
264.9% | 350.6% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
6.4 mo | 9.7 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
30.3% | 20.6% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
50.4% | 92.8% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
2.9% | 8.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-10.3% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
7.9% | 2.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $15.2M | $14.0M | $7.4M | 77.3% | 53 |
| 2024 | $14.8M | $15.6M | $6.1M | 79.4% | 56 |
| 2023 | $13.7M | $14.2M | $6.8M | 80.5% | 57 |
| 2022 | $15.0M | $14.2M | N/A | — | 61 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.